echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medical World News > Food and Drug Administration: Temporarily extend the time limit for supplementary information for drug registration applications

    Food and Drug Administration: Temporarily extend the time limit for supplementary information for drug registration applications

    • Last Update: 2022-10-19
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    In order to thoroughly implement the decision-making and deployment of the Party Central Committee and the State Council on doing a good job in the "six stability" work and implementing the "six guarantees" task, support drug research and development, and promote the development of the pharmaceutical industry, it is decided to temporarily extend the time limit for supplementary information for drug registration applications, which is hereby announced as follows: 1.
    For drug registration applications under review that have been issued by the Drug Review Center of the State Food and Drug Administration but have exceeded the time limit for supplementary information, the time limit for supplementary information shall be extended by 80 working days
    from the date of issuance of the announcement 。 2.
    For drug registration applications that have issued the Notice of Supplementary Information and are still within the time limit for supplementary information, the time limit for supplementary information shall be extended by 80 working days on the basis of the original time limit of 80 working days
    .
    3.
    For drug registration applications issued by the Drug Review Center of the State Food and Drug Administration from the date of this announcement to December 31, 2022, the time limit for supplementary information is extended to 160 working days
    .
    This is hereby announced
    .
    NMPA October 14, 2022
    ={"common":{"bdSnsKey":{},"bdText":"","bdMini":"1","bdMiniList":false,"bdPic":"","bdStyle":"0","bdSize":"32"},"share":{},"image":{"viewList":[" weixin","sqq","qzone","tsina","tqq","tsohu","tieba","renren","youdao","fx","ty","fbook","twi","copy","print"],"viewText":"Share to:","viewSize":"24"},"selectShare":{" bdContainerClass":null,"bdSelectMiniList":["weixin","sqq","qzone","tsina","tqq","tsohu","tieba","renren","youdao","fx","ty","fbook","twi","copy","print"]}}; with(document)0[(getElementsByTagName('head')[0]|| body).
    appendChild(createElement('script')).
    src='http://bdimg.
    share.
    baidu.
    com/static/api/js/share.
    js?v=89860593.
    js?cdnversion='+~(-new Date()/36e5)];
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.